These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2656435)

  • 1. [Effects of antiarrhythmic drugs on canine ventricular arrhythmia models].
    Hashimoto K
    Nihon Yakurigaku Zasshi; 1989 Feb; 93(2):29-39. PubMed ID: 2656435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness?
    Hashimoto K; Haruno A; Matsuzaki T; Sugiyama A; Akiyama K
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():805-17. PubMed ID: 1657110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
    Hashimoto K; Ishii M; Komori S; Mitsuhashi H
    Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic effects of optical isomers of cibenzoline on canine ventricular arrhythmias.
    Haruno A; Matsuzaki T; Hashimoto K
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):376-82. PubMed ID: 1700207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of the antiarrhythmic effect of drugs on canine ventricular arrhythmias by the determination of minimum effective plasma concentrations.
    Hashimoto K; Shibuya T; Satoh H; Imai S
    Jpn Circ J; 1983 Jan; 47(1):92-7. PubMed ID: 6827775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmia models for drug research: classification of antiarrhythmic drugs.
    Hashimoto K
    J Pharmacol Sci; 2007 Apr; 103(4):333-46. PubMed ID: 17409630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic profile of a new class 1 drug, AHR 10718, on canine atrial and ventricular arrhythmia models.
    Mitsuhashi H; Hashimoto K
    Jpn J Pharmacol; 1988 Apr; 46(4):349-58. PubMed ID: 3404765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic effects of a new drug, E-0747, on canine ventricular arrhythmia models.
    Mitsuhashi H; Akiyama K; Hashimoto K; Sawa Y; Hatori Y
    Jpn J Pharmacol; 1987 Jun; 44(2):155-62. PubMed ID: 3656773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic effects of coronary vasodilators on canine ventricular arrhythmia models.
    Komori S; Ishii M; Hashimoto K
    Jpn J Pharmacol; 1985 May; 38(1):73-82. PubMed ID: 4021230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, nicainoprol, on canine ventricular arrhythmias.
    Hashimoto K; Akiyama K; Mitsuhashi H
    Jpn J Pharmacol; 1989 Feb; 49(2):245-54. PubMed ID: 2733262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
    Xue YX; Arita J; Aye NN; Hashimoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new antiarrhythmic drug, SD-3212, on canine ventricular arrhythmia models.
    Hirasawa A; Haruno A; Matsuzaki T; Hashimoto K
    Jpn Heart J; 1992 Nov; 33(6):851-61. PubMed ID: 1299746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic effects of the class 1c antiarrhythmic drug, flecainide, on canine ventricular arrhythmia models.
    Akiyama K; Hashimoto K
    Jpn Heart J; 1989 Jul; 30(4):487-95. PubMed ID: 2509760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs.
    Chen J; Xue Y; Eto K; Ni C; Hashimoto K
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):576-84. PubMed ID: 8891885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of KT-362, a new Na and Ca influx and Ca release inhibitor, on canine ventricular arrhythmias.
    Hashimoto K; Watanabe K; Mochizuki S; Tomiyama A
    Jpn J Pharmacol; 1989 Dec; 51(4):475-82. PubMed ID: 2559225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo antiarrhythmic profile of AP-792 assessed in different canine arrhythmia models.
    Takahara A; Hirasawa A; Dohmoto H; Shoji M; Yoshimoto R; Sugiyama A; Hashimoto K
    Jpn J Pharmacol; 2001 Sep; 87(1):21-6. PubMed ID: 11676194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, AN-132, on ventricular arrhythmias in beagles.
    Hashimoto K; Watanabe K; Mitsuhashi H
    Cardiovasc Drugs Ther; 1989 Oct; 3(5):683-9. PubMed ID: 2488108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic effects of a novel class III drug, KCB-328, on canine ventricular arrhythmia models.
    Xue Y; Tanabe S; Nabuchi Y; Hashimoto K
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):239-47. PubMed ID: 9700986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic plasma concentrations of cibenzoline on canine ventricular arrhythmias.
    Hashimoto K; Akiyama K; Mitsuhashi H
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):148-53. PubMed ID: 2435991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic and cardiohemodynamic effects of a novel Ca(2+) channel blocker, AH-1058, assessed in canine arrhythmia models.
    Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
    Eur J Pharmacol; 2000 Jun; 398(1):107-12. PubMed ID: 10856454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.